Gambling disorder and comorbid behavioral addictions: Demographic, clinical, and personality correlates

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
TANG, Karen T. Y.
KIM, Hyoun S.
HODGINS, David C.
MCGRATH, Daniel S.
Citação
PSYCHIATRY RESEARCH, v.284, article ID 112763, 8p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Gambling disorder (GD) frequently co-occurs with substance use disorders. However, the extent to which GD co-occurs with behavioral addictions (BAs) and the demographic, clinical, and personality correlates of comorbid GD and BA is largely unknown. The aims of the present research were to address this gap among people seeking treatment for GD (N = 458) in Sao Paulo, Brazil. Structured clinical interviews diagnosed individuals with GD and other psychiatric disorders. The Shorter PROMIS questionnaire was used to identify BAs (work, exercise, food bingeing, sex, and shopping). Questionnaires assessed demographic characteristics, gambling behavior, and personality. Of the total sample, 206 (45.0%) participants met the criteria of having at least one behavioral addiction (GD+BA). The most common comorbid BA was food bingeing (8.1%) with the least common being exercise (3.6%). In a multivariate logistic regression, individuals with GD + BA tended to be younger, and had greater rates of comorbid post-traumatic stress disorder and bulimia nervosa compared to participants who did not present with a comorbid BA. Taken together, individuals with GD + BA present with increased psychopathology. These results may have important implications for the assessment and treatment of individuals with GD and comorbid BAs.
Palavras-chave
Gambling disorder, Work addiction, Exercise addiction, Binge eating addiction, Sex addiction, Shopping addiction
Referências
  1. Abdollahnejad R, 2014, ADDICT BEHAV, V39, P566, DOI 10.1016/j.addbeh.2013.11.004
  2. Alvarez-Moya EM, 2010, CAN J PSYCHIAT, V55, P498, DOI 10.1177/070674371005500804
  3. Amorim P., 2000, REV BRAS PSIQUIATR, V22, P106, DOI 10.1590/S1516-44462000000300003
  4. Andreassen CS, 2012, SCAND J PSYCHOL, V53, P265, DOI 10.1111/j.1467-9450.2012.00947.x
  5. [Anonymous], 2013, DIAGN STAT MAN MENT
  6. Argo T.R., 2004, PATHOLOGICAL GAMBLIN
  7. Back S, 2000, AM J ADDICTION, V9, P51
  8. Barnes GM, 2011, AM J ADDICTION, V20, P166, DOI 10.1111/j.1521-0391.2010.00116.x
  9. Black DW, 1997, AM J PSYCHIAT, V154, P243
  10. Bottesi G, 2015, J GAMBL STUD, V31, P825, DOI 10.1007/s10899-014-9470-5
  11. Brady KT, 2004, CURR DIR PSYCHOL SCI, V13, P206, DOI 10.1111/j.0963-7214.2004.00309.x
  12. Brown VB, 1999, J PSYCHOACTIVE DRUGS, V31, P31, DOI 10.1080/02791072.1999.10471723
  13. Brown VB, 2013, J PSYCHOACTIVE DRUGS, V45, P386, DOI 10.1080/02791072.2013.844381
  14. Calado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073
  15. Carlotta D, 2015, J PERS DISORD, V29, P378, DOI 10.1521/pedi_2014_28_164
  16. Christo G, 2003, ADDICT BEHAV, V28, P225, DOI 10.1016/S0306-4603(01)00231-3
  17. Ciccarelli M, 2020, J GAMBL STUD, V36, P243, DOI 10.1007/s10899-019-09872-x
  18. Claus RE, 2002, J PSYCHOACTIVE DRUGS, V34, P25, DOI 10.1080/02791072.2002.10399933
  19. Cloninger C. R., 1999, TEMPERAMENT CHARACTE
  20. Cowie ME, 2019, J BEHAV ADDICT, V8, P451, DOI 10.1556/2006.8.2019.35
  21. Marques JMD, 2008, GEN HOSP PSYCHIAT, V30, P303, DOI 10.1016/j.genhosppsych.2008.02.001
  22. de Mattos CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167365
  23. Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0
  24. Del Pino-Gutierrez A, 2017, J BEHAV ADDICT, V6, P396, DOI 10.1556/2006.6.2017.051
  25. DellOsso B., 2005, CLIN PR EPIDEMOL MEN, V1, P54
  26. Dowling NA, 2015, AUST NZ J PSYCHIAT, V49, P519, DOI 10.1177/0004867415575774
  27. Dwyer R, 2016, HEALTH SOCIOL REV, V25, P223, DOI 10.1080/14461242.2016.1184581
  28. Fernandez-Aranda F, 2019, J BEHAV ADDICT, V8, P123, DOI 10.1556/2006.8.2019.08
  29. Frascella J, 2010, ANN NY ACAD SCI, V1187, P294, DOI 10.1111/j.1749-6632.2009.05420.x
  30. Fuentes D., 2000, ESCALAS AVALIACAO CL, P363
  31. Galetti AM, 2017, REV BRAS PSIQUIATR, V39, P36, DOI 10.1590/1516-4446-2016-1911
  32. Grant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184
  33. Grant JE, 2005, COMPR PSYCHIAT, V46, P34, DOI 10.1016/j.comppsych.2004.07.022
  34. Grant JE, 2003, ACTA PSYCHIAT SCAND, V108, P203, DOI 10.1034/j.1600-0447.2003.00162.x
  35. Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884
  36. Grant JE, 2005, SEX ADDICT COMPULS, V12, P235, DOI 10.1080/10720160500203856
  37. Guerrero-Vaca D, 2019, J GAMBL STUD, V35, P261, DOI 10.1007/s10899-018-9786-7
  38. Guo K, 2017, ADDICT BEHAV, V67, P26, DOI 10.1016/j.addbeh.2016.11.021
  39. Hall GW, 2000, AM J PSYCHIAT, V157, P1127, DOI 10.1176/appi.ajp.157.7.1127
  40. Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196
  41. Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X
  42. Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184
  43. Janiri L, 2007, SUBST USE MISUSE, V42, P975, DOI 10.1080/10826080701202445
  44. Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900
  45. Kim HS, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00406
  46. Kim HS, 2018, EUR EAT DISORD REV, V26, P508, DOI 10.1002/erv.2606
  47. Kim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008
  48. Ladd GT, 2003, EXP CLIN PSYCHOPHARM, V11, P202, DOI 10.1037/1064-1297.11.3.202
  49. Lichtenstein MB, 2014, PSYCHIAT RES, V215, P410, DOI 10.1016/j.psychres.2013.11.010
  50. Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x
  51. Malloy-Diniz L.F., 2010, J BRAS PSIQUIAT, V59, P99, DOI 10.1590/S0047-20852010000200004
  52. Maraz A, 2016, ADDICTION, V111, P408, DOI 10.1111/add.13223
  53. Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8
  54. Monok K, 2012, PSYCHOL SPORT EXERC, V13, P739, DOI 10.1016/j.psychsport.2012.06.003
  55. Mustelin L, 2017, APPETITE, V109, P165, DOI 10.1016/j.appet.2016.11.032
  56. Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
  57. Petry NM, 2003, J NERV MENT DIS, V191, P399, DOI 10.1097/01.NMD.0000071589.20829.DB
  58. Preti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003
  59. Read JP, 2014, PSYCHOL ADDICT BEHAV, V28, P1052, DOI 10.1037/a0038348
  60. Schaffer S D, 1990, Nurse Pract, V15, P25
  61. Slutske WS, 2005, ARCH GEN PSYCHIAT, V62, P769, DOI 10.1001/archpsyc.62.7.769
  62. Souza T., 2008, BEHAV ANAL TODAY, V9, P11, DOI 10.1037/H0100643
  63. Steenbergh TA, 2002, PSYCHOL ADDICT BEHAV, V16, P143, DOI 10.1037//0893-164X.16.2.143
  64. Sterling S, 2011, ALCOHOL RES HEALTH, V33, P338
  65. Sussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI [10.1177/0163278710380124, 10.1177/0163278709360274]
  66. Szabo A., 2007, INT J MENT HEALTH AD, V5, P25, DOI 10.1007/S11469-006-9050-8
  67. Tabachnick B.G., 2012, USING MULTIVARIATE S, DOI [10.1037/022267, DOI 10.1037/022267]
  68. Tavares H, 2003, J CLIN PSYCHIAT, V64, P433, DOI 10.4088/JCP.v64n0413
  69. Winters Ken C, 2003, J Gambl Stud, V19, P261, DOI 10.1023/A:1024203403982
  70. World Health Organization, 2018, INT CLASS DIS 11 REV
  71. Yakovenko I, 2018, INT GAMBL STUD, V18, P143, DOI 10.1080/14459795.2017.1364400
  72. Yucel M, 2019, ADDICTION, V114, P1095, DOI 10.1111/add.14424